Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Rapid solubilization and translocation of /sup 109/CdO following pulmonary deposition. [Rats]

Journal Article · · Toxicol. Appl. Pharmacol.; (United States)
In order to examine the translocation of CdO from the respiratory surfaces rats were given an intratracheal instillation of cadmium oxide tagged with /sup 109/Cd. The half-life of the /sup 109/Cd in lung was about 4 h, at which time nearly 40% of the /sup 109/Cd body burden was in the liver. At 24 h following instillation, the distribution of /sup 109/Cd was: lung, 23.9%; liver, 58.4%; kidney, 2.7%; and testes, 0.22%. At 2 weeks after instillation the lung, liver, and kidney had 18, 57, and 8% respectively, of the body burden. Less than 10% of the instilled /sup 109/Cd was excreted during the first 2 weeks. These data suggest that inhaled CdO is highly soluble in the lung but that cadmium is slowly excreted from the body, resulting in a long-term dose commitment to several tissues.
Research Organization:
Pacific Northwest Lab., Richland, WA
DOE Contract Number:
EY-76-C-06-1830
OSTI ID:
5791516
Journal Information:
Toxicol. Appl. Pharmacol.; (United States), Journal Name: Toxicol. Appl. Pharmacol.; (United States) Vol. 54; ISSN TXAPA
Country of Publication:
United States
Language:
English